Price Differentiation and Transparency in the Global Pharmaceutical Marketplace
- 1 January 2005
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 23 (7) , 651-658
- https://doi.org/10.2165/00019053-200523070-00002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001International Journal of Health Economics and Management, 2005
- The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990sHealth Economics, 2004
- Net Health Plan Savings From Reference Pricing for Angiotensin-Converting Enzyme Inhibitors in Elderly British Columbia ResidentsMedical Care, 2004
- Differential Pricing of Pharmaceuticals in the Internet AgeThe Journal of Ambulatory Care Management, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Prices And Availability Of Pharmaceuticals: Evidence From Nine CountriesHealth Affairs, 2003
- Pharmaceuticals and the Developing WorldJournal of Economic Perspectives, 2002
- Differential pricing of drugs: a role for cost-effectiveness analysis?The Lancet, 2002
- International Price Comparisons for PharmaceuticalsPharmacoEconomics, 1998
- A Theory of OligopolyJournal of Political Economy, 1964